2020 Innovations in Pain Therapies, COVID-19 Treatments, Cell Therapies, and Biomarker Technologies - ResearchAndMarkets.com

DUBLIN--()--The "Recent Innovations in Pain Therapies, COVID-19 Treatments, Cell Therapies, and Biomarker Technologies" report has been added to ResearchAndMarkets.com's offering.

This edition of the Life Science, Health & Wellness TechVision Opportunity Engine (TOE) encompasses latest advances across life sciences, health and wellness. The TOE include innovations related to pain management, COVID-19 treatment, and biomarker platforms. It also includes innovations related to rare disease management, bioluminescence, obesity management, and cell and gene therapies.

Key Topics Covered

  1. Non-opioid-based Pain Reliever for Bone Metastases
  2. Gene Therapy-based Treatment for Chronic Pain
  3. A Non-narcotic Pain Reliever for Migraine
  4. Patch-based Technology for Pain Relief
  5. Intravenous Treatment for Migraine Relief in Launch Stage
  6. Partially Invasive Nerve Stimulator to Solve Pain
  7. Neurostimulator for the Treatment of Fibromyalgia
  8. A Smart Wearable Device for Pain Relief
  9. Bioluminescence to Detect Early Tooth Decay
  10. Drug Repurposing as a Novel Treatment for Triple Negative Breast Cancer
  11. An In Vitro Diagnostic Test for Diagnosis of COVID-19
  12. CE Marking Grants European Approval for COVID-19 Diagnostic Test
  13. Promising Novel Multi-specific Immuno-oncology Drug in Development
  14. Proprietary Multi-Specific Antibody Discovery and Engineering Platform
  15. Beta-3 Agonist Drug as a Treatment for Overactive Bladder
  16. Vibegron Awaiting FDA Approval After Successful NDA Application
  17. Novel Biodegradable Intracameral Ophthalmic Implant
  18. FDA Approves Drug Implant for Open Angle Glaucoma And Ocular Hypertension
  19. Uncovering Mechanism of an Existing Obesity Drug
  20. GLP-1 Receptors and GABA Neurons as New Drug Targets for Obesity
  21. Novel Technology Platform Based on T-Cell Engagers and CAR-Ts
  22. Development of Novel Immunotherapies Against Solid Tumor Treatment
  23. Targeting Specific Proteases for Treatment of COVID-19
  24. Potential Treatment and Drug Target Against Coronaviruses
  25. Novel Drug Candidates Designed to Combat Bacterial Infections
  26. Novel Drug Candidates Designed to Combat Bacterial Infections and Rare Diseases
  27. Drug Delivery through the Cell's Natural Communications System
  28. Circulating Tumor Cells Detection through a Novel Technology
  29. Insulin Producing Transplantable Stem Cell Technology
  30. Controlled and Prolonged Release of Local Medication
  31. Severe Dengue Prediction Assay
  32. Personalized Biomarker Diagnostics
  33. Gene Therapy for Muscular Wasting
  34. Liposome-based Pulmonary Drug Delivery System
  35. Industry Influencers
  36. Key Contacts

For more information about this report visit https://www.researchandmarkets.com/r/n2qh3l

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900